Revvity | PKI - 债务



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.11B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


债务 更改 日
Agilent USD 3.35B 0 2025-12
Align Technology USD 116.04M 1.6M 2026-03
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 1.38B 7.9M 2026-03
Bruker USD 1.67B 371.6M 2026-03
Celltrion KRW 160.58B 733.3M 2026-03
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 70M 30M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Illumina USD 2.54B 9M 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 16.24B 408M 2026-06
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
OraSure Technologies USD 782K 465K 2024-06
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pharma Mar EUR 45.84M 1.7M 2026-06
Qiagen NV USD 1.65B 165.82M 2026-03
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.87B 40.8M 2026-03
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Tilray USD 640.95M 35.17M 2022-06
Waters USD 5.57B 4.08B 2026-03
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03